{"id":114875,"date":"2026-10-23T17:38:32","date_gmt":"2026-10-23T17:38:32","guid":{"rendered":"https:\/\/pakistaninewspaperlist.com\/news\/fortrea-dan-omico-bekerjasama-memajukan-pembangunan-ubat-onkologi-dipacu-biomarker\/"},"modified":"2026-10-23T17:38:32","modified_gmt":"2026-10-23T17:38:32","slug":"fortrea-dan-omico-bekerjasama-memajukan-pembangunan-ubat-onkologi-dipacu-biomarker","status":"publish","type":"post","link":"https:\/\/pakistaninewspaperlist.com\/news\/fortrea-dan-omico-bekerjasama-memajukan-pembangunan-ubat-onkologi-dipacu-biomarker\/","title":{"rendered":"Fortrea dan Omico Bekerjasama Memajukan Pembangunan Ubat Onkologi Dipacu Biomarker"},"content":{"rendered":"<div id=\"main-body-container\" itemprop=\"articleBody\">\n<p><strong>Sorotan<\/strong><\/p>\n<ul type=\"disc\">\n<li style=\"margin-bottom:8pt;\">Kerjasama ini bertujuan untuk mempercepatkan penyelidikan onkologi ketepatan di Australia<\/li>\n<li style=\"margin-bottom:8pt;\">Menggabungkan pengalaman Fortrea dalam kajian klinikal onkologi dengan program Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT) milik Omico<\/li>\n<li style=\"margin-bottom:8pt;\">Secara bersama, Fortrea dan Omico meningkatkan kecekapan pemilihan tapak kajian serta mempercepatkan akses pesakit kepada kajian klinikal dipacu biomarker yang relevan melalui pemadanan pesakit dengan kajian tersebut<\/li>\n<\/ul>\n<p>DURHAM, North Carolina dan SYDNEY, Oct.  24, 2026  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=R90OW9pkJ1cIbDQvlKqkddQhZkL1okjx84BOU_VyNWi6C7EuC1e8IIJKFwlVyoM3vmKytXc5VN4IEWHqWhFuGw==\" rel=\"nofollow\" target=\"_blank\" title=\"Fortrea\">Fortrea<\/a>\u00a0(Nasdaq: FTRE) (&#8220;Syarikat&#8221;), sebuah organisasi penyelidikan kontrak (CRO) global terkemuka dan Omico, organisasi terkemuka di Australia dalam saringan onkologi ketepatan dan pemadanan kajian klinikal, hari ini mengumumkan kerjasama untuk mempercepatkan penyelidikan onkologi ketepatan dengan membantu menghubungkan memadankan pesakit kanser dengan kajian klinikal berdasarkan biomarker. Dengan menggabungkan rangkaian onkologi ketepatan Omico bersama kepakaran saintifik dan pengalaman kajian klinikal Fortrea, usaha sama ini bertujuan meningkatkan perancangan kajian, pemilihan tapak penyelidikan dan perekrutan pesakit bagi memperluas akses kepada penyelidikan onkologi dipacu biomarker di peringkat global.<\/p>\n<p>Melalui inisiatif ini, Omico akan menyokong pelanggan Fortrea dalam keperluan pembangunan ubat onkologi mereka dengan menyediakan akses kepada cerapan populasi pesakit, termasuk pemprofilan genomik, keupayaan pemadanan kajian klinikal, data onkologi dunia nyata serta laluan rujukan pesakit di Australia, sebuah negara penting bagi aktiviti penyelidikan klinikal onkologi peringkat awal dan lewat. Kerjasama ini akan menggabungkan pengalaman Fortrea dalam pembangunan ubat onkologi dengan program utama Omico, iaitu Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT), inisiatif genomik kanser terbesar di Australia. PrOSPeCT direka untuk menyediakan pemprofilan molekul dan membantu memadankan pesakit dengan kajian klinikal serta terapi bersasar yang dipacu biomarker.<\/p>\n<p>&#8220;Kami menjalin kerjasama dengan Omico bagi memastikan pesakit yang sesuai dapat dipadankan dengan kajian yang tepat secepat mungkin,&#8221; kata Oren Cohen, M.D., Ketua Pegawai Perubatan Fortrea. \u201cPembangunan onkologi moden menuntut tahap ketepatan yang semakin tinggi untuk memadankan jenis kanser tertentu dengan terapi yang berpotensi memberikan manfaat terbaik kepada pesakit serta melaksanakannya secepat mungkin. Kerjasama kami dengan Omico mempercepatkan keupayaan kami mengenal pasti pesakit yang sesuai untuk kajian dipacu biomarker di Australia serta membantu memajukan perubatan ketepatan bagi pesakit kanser.\u201d<\/p>\n<p>Omico telah membangunkan salah satu ekosistem onkologi ketepatan yang paling komprehensif di Australia, yang menggabungkan pemprofilan molekul, bukti dunia nyata, program penyelidikan kohort serta rangkaian penyelidik dan tapak klinikal di seluruh negara. Omico melaporkan lebih daripada 23,000 pesakit yang telah memberikan persetujuan untuk dimasukkan ke dalam pangkalan data klinikal-genomiknya dan telah menerima rujukan daripada lebih 1,600 pengamal klinikal di seluruh Australia.<\/p>\n<p>\u201cAustralia berada pada kedudukan yang kukuh untuk menyokong kajian klinikal global dipacu biomarker menerusi infrastruktur penyelidikan onkologi ketepatan kebangsaan, kepakaran dan rangkaian Omico yang telah mantap,\u201d kata Profesor David Thomas, Ketua Pegawai Sains dan Strategi Omico. \u201cDengan menggabungkan data kebangsaan serta keupayaan pemadanan kajian klinikal kami dengan kepakaran pembangunan klinikal global Fortrea, kami dapat membantu penaja antarabangsa mengenal pasti populasi pesakit yang relevan, merancang kajian dengan lebih berkesan dan menyokong perekrutan peserta tersasar.\u201d<\/p>\n<p>Kepakaran onkologi Fortrea disokong oleh ribuan profesional operasi serta lebih daripada 50 doktor onkologi yang berkhidmat dalam organisasi tersebut. Kerjasama ini terjalin ketika pembangunan ubat onkologi moden semakin memberi tumpuan kepada perubatan ketepatan, pembangunan dipacu biomarker dan pengenalpastian pesakit secara bersasar. Melalui kerjasama ini, Fortrea dan Omico boleh menawarkan pemilihan tapak penyelidikan yang lebih cekap serta keupayaan memadankan pesakit dengan kajian yang sesuai berdasarkan data genomik unik mereka, sekali gus membolehkan lebih ramai individu menyertai kajian yang disesuaikan dengan keadaan penyakit masing-masing di Australia.<\/p>\n<p><strong>Perihal Fortrea<\/strong><br \/>Fortrea (Nasdaq: FTRE) ialah penyedia global terkemuka bagi penyelesaian pembangunan klinikal untuk industri sains hayat. Kami bekerjasama dengan syarikat biofarmaseutikal, bioteknologi, peranti perubatan dan diagnostik yang baru muncul dan besar untuk memacu inovasi penjagaan kesihatan yang mempercepatkan terapi mengubah hidup kepada pesakit yang memerlukan. Fortrea menyediakan pengurusan percubaan klinikal fasa I-IV, farmakologi klinikal dan perkhidmatan perundingan. Penyelesaian Fortrea memanfaatkan lebih tiga dekad pengalaman merangkumi lebih daripada 20 bidang terapeutik, disokong oleh komitmen terhadap ketelitian saintifik, cerapan mendalam serta rangkaian tapak penyelidik yang kukuh. Pasukan kami yang berbakat dan pelbagai di sekitar 100 negara mampu menyediakan penyelesaian berfokus dan tangkas kepada klien global. Ketahui lebih lanjut tentang bagaimana Fortrea memperkemas pembangunan ubat di\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=R90OW9pkJ1cIbDQvlKqkdTd04IB6HxwbJzTW786MG3u_LOkIiVm2w1X6kXAlWoXPO8e0yBHmPxERyhI4Q8f4Jk855IvBHc9YekCjz19v6l270X9CZmdpVeuewhpImcDAxnosfWA7muo_2SG54juocsSSLyJ2Eyt-Ke5JKZQUF5q8lLAjfxIym41ZwDLAZBrRReeP0vHus8zLdA2GD_LcCAFZepNurK1ArJ0u5CKurs1N8b-HKWCIgLKQ9rsiqLmpu-u58ASlgjrDpW-S4OHQ_1cKu3xSMSy0knXoZ7rJ0xZ9Aur4zFEX2gAM5OH0piPeXVVgFHSkRUeZ3r6_cWwUdF7rpCGYvcBF6EUTcXsR3gRgFDdQIjqFEWyfym8Hx5zlLgi_ExZ9rZdw6YEJnlBDl_VSrnxrXZdLlXly_4XM9UQ_QU71Sql_dmcCifM7W4OraT6r6N_E4WHk6N4mrIoKIwhbK1n9WAka08R0GvtaprnJb__mesV8GvfqicalU-TrziHM1UxfEz-2Uo8I_5Qx8jrZ63ijRLmYpSS5hF7ecxzRuMxdr3HutdeaKfOZpDHQJQ9k0gJ0ikG55DOT8DAE0XiRsPxe8VoSrHgErfJ4keloS9Mqm6tdFH01YdETTZe6R25L64Y9sh7I48LAROP-PY090pJqi8OReBkN72ytXWc=\" rel=\"nofollow\" target=\"_blank\" title=\"Fortrea.com\">Fortrea.com<\/a>\u00a0dan ikuti kami di\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JQ96GipnsdgW16FEE8fYqd229nnPIeHesLPn_l0dEdaHRq92nCYKVGXIrXFCROpjBhe0PLQvcc06EbgIHlrFWQWWd_jkyoj9NZWAXB_wmHWQFJwnzHTngGDRxz25jubjtyg4eB_1-x5KTNJBdcCcemN22qYnOA5S7khBarLl9f6Q04oDmzkOyP8-2iYcsp5GceRsw2GWHLtEb8x2qrIXgG9RXVfxwjIMdioDJe80lLNssyxoYwH6JW62oEL-ZImkgdDrabgNGlqltMa4MsU0UNZRBDaScUzIuZ7juPCoZPB6f0GNSWu9Oze66Pk8hUlKO4rd6zttVJ5lpfMk-xTaSgXc3gFM4x7Fl_mfH0XIfPKkPJTxflNqHgxJtx0kHcKAXoiZhqFklr9ZnSXwUsGgOaLTpYjzPJnpL0ht5VNtSAtBEOGxMK49AKc-F2291LpYcPkjAKK6Ro7jVC-wQxEJqnRTS4oVB_TGLdEGDpODCc66Nps3H5I1lodmNQr1SPCaEjrBumtL5QR71nzdEeFKIlMLd1dD7X5LmiJaI88W7uloSF1AWUW4VaRiojS-fJQFAGcoJOXPsGONUlGDZSE6T4KJ1KBQIWJkjr9PwMWvCi0th1bkrLVE8xo69rRFLN1i9xbzv6DxMkFbOyd7jSAFJVGISaShfppTvFBTP4KGjXDJ1ZWwoArO1eswP_YbgcOp\" rel=\"nofollow\" target=\"_blank\" title=\"LinkedIn\">LinkedIn<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1VBWFRguNIdXX4axFbapdx4vgodNJjlro-2-xBpUnlX77pchJfL68xvytti3iFKPVKbl9LTEJiaRRZkJR-SN-WXgbVMR5EpPI7YPVYZZy05iC9K-j3EtHEzpUx2vQCeEMn7-WFtIDcQjjUg6SoDw-cW_V__CFUisqZM8_xeRA9yJh7oEOyuygglxk7UaPmPudoq_hiplm7_hJuiquoTmlbB4WICJv4q5h7CEj1Gm06BvYSR6JuVK2NWpSowiVucvtnPltyxsjYwbn9SKM3Os0lnGcnlo3Youk3bjFGvlWq-MAJEWz7Wz0WjBpT0fE51STxn9qaAb8R_i6Wz0fUHBg3665UTrXO6xA1LV0LNnnfxVmasdz7eBz-TckCZbooQ6_-Avbl3U62aU5ryfJKOtTSVUMxDsLAzJCbggK9nLxxfBBi2l7fbsklMC5c74af2w1S18fPdNdYtP1yG25q6sieQIHO-ZQX-Gm8SoQVp4SKSvfISRkXn2j557vhtba0e4LOfJyg_DA4tmN2XOrJAh9eXAKVYXpjyIB0Z0E2ZqtFlkdDMbB0nqFfQRXxQlyffir1TsKgoKtNnlHcFvdu1v5Q==\" rel=\"nofollow\" target=\"_blank\" title=\"X\">X<\/a>\u00a0serta\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GvF3BDmx9OJ0kxB2pPLB17WqWY5IgRb8Tkz6Rokz05eTydRujUBxKy_pHbr6h0qywv-2QsasZzFqvo6WtROlwhYg5rxdp5zmuhGJmvXdPbY=\" rel=\"nofollow\" target=\"_blank\" title=\"Bluesky\">Bluesky<\/a>.<\/p>\n<p><strong>Perihal Omico<\/strong><br \/>Omico ialah sebuah organisasi kebangsaan bebas dan bukan untung yang mengubah cara kita memerangi kanser. Kami berusaha meningkatkan hasil rawatan bagi rakyat Australia yang menghidap kanser dengan menyediakan akses yang saksama kepada onkologi persis, menerapkan kemajuan saintifik dalam penjagaan klinikal dan penyelidikan, serta menjana bukti yang diperlukan bagi memaklumkan penggubalan dasar kesihatan dan reformasi sistem kesihatan. Dengan kerjasama institut kanser terkemuka Australia, penyelidik, pengamal klinikal, rakan industri, kumpulan advokasi dan kerajaan, Omico mempercepatkan pemprofilan molekul, kajian klinikal dipacu biomarker, pengurusan risiko kanser diperibadikan serta penjanaan bukti dunia nyata.<\/p>\n<p><strong>Perihal PrOSPeCT<\/strong><br \/>PrOSPeCT ialah inisiatif onkologi ketepatan terbesar di Australia. Program ini dilancarkan oleh Omico bersama rangkaian kebangsaan rakan penjagaan kesihatan, penyelidikan dan industri dan menyediakan akses kepada pemprofilan molekul serta pemadanan kepada kajian klinikal dan terapi dipacu biomarker secara percuma untuk rakyat Australia yang layak. Selain itu, program ini menjana data klinikal, genomik, rawatan dan hasil klinikal yang memajukan penyelidikan, meningkatkan penjagaan kanser, serta menyokong pembangunan dasar kesihatan pada masa hadapan.<\/p>\n<p><strong>Hubungan Fortrea:<\/strong><br \/>Galen Wilson (Media) \u2013 703-298-0802,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WD48cYgXMBKsDDxvk-qhekw_1E08fv8XWkZDreXcMoWrFkbDt28B4pvVkeVkfkYLECBN_UPi8-Q4OEGeKfZnLLWkSQYRd-bO6uQQXGNv3lU=\" rel=\"nofollow\" target=\"_blank\" title=\"media@fortrea.com\">media@fortrea.com<\/a><br \/>Kate Dillon (Media) \u2013 646-818-9115,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=oYBwaxoezynjl7axfDui2XeY0X5EcAQu6K38Pht8hOpnwE7tqfAtRBJThPDCqA_nIKt_t_C45TpKBk36RZqjNT-tMbLJuT3-mVC81TU9o1g=\" rel=\"nofollow\" target=\"_blank\" title=\"kdillon@prosek.com\">kdillon@prosek.com<\/a><br \/>Tracy Krumme (Pelabur) \u2013 984-385-6707,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fli2XCrpjgbUHS_Lw-Gpmdx58QJKWBVkjS82_khX4GHpwErap4ezCIvqwetoy68CgbT7GrnRYL3UYjaWVNo3ndD9YIkW2OcI8HAi3Yw86qa7IhGRVbuTonl6qtIQhkGTPW8S4ZiZqrOS9UJUYyY58ct1eHnJg8LqQBBaiBQlaBxJGSzYgGahcfmaG3CY7Ylw8_7J1qNuxPsaMjr6u26FIQSzqtE8NJ9bFGkMtpWVFIWfbWqS2J2UtNQytRQOyFnYviHYDJhn-tnm28m8TCRAgai299XRUZrK9SyoMOCOQjY=\" rel=\"nofollow\" target=\"_blank\" title=\"Tracy.Krumme@fortrea.com\">Tracy.Krumme@fortrea.com<\/a><\/p>\n<p><strong>Hubungi Omico:<\/strong><br \/>Kym Bramich (Komunikasi) \u2013 +61 414 795 087,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QXtFO5EDaWghb16kBbWFrSzkj-zDy9YLPDuIRfNS_Yltk3ClQiwyjUoErPYYJjZh-p2TPR4u5b2QSmZYXW3BqskYZnJ9MKP168-bH9QW64Y=\" rel=\"nofollow\" target=\"_blank\" title=\"k.bramich@omico.org.au\">k.bramich@omico.org.au<\/a><\/p>\n<p>\n            <\/div>\n","protected":false},"excerpt":{"rendered":"<p>Sorotan Kerjasama ini bertujuan untuk mempercepatkan penyelidikan onkologi ketepatan di Australia Menggabungkan pengalaman Fortrea dalam kajian klinikal onkologi dengan program Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT) milik Omico Secara bersama, Fortrea dan Omico meningkatkan kecekapan pemilihan tapak kajian serta mempercepatkan akses pesakit kepada kajian klinikal dipacu biomarker yang relevan melalui pemadanan pesakit dengan [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":114876,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"fifu_image_url":"https:\/\/ml.globenewswire.com\/Resource\/Download\/9fbbe00b-8782-464e-83e6-5843c563884a","fifu_image_alt":"","footnotes":""},"categories":[208],"tags":[],"class_list":["post-114875","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-globenewswire"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.2 - aioseo.com -->\n\t<meta name=\"description\" content=\"Sorotan Kerjasama ini bertujuan untuk mempercepatkan penyelidikan onkologi ketepatan di AustraliaMenggabungkan pengalaman Fortrea dalam kajian klinikal onkologi dengan program Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT) milik OmicoSecara bersama, Fortrea dan Omico meningkatkan kecekapan pemilihan tapak kajian serta mempercepatkan akses pesakit kepada kajian klinikal dipacu biomarker yang relevan melalui pemadanan pesakit dengan kajian tersebut\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"Gias Ul Hassan\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/pakistaninewspaperlist.com\/news\/fortrea-dan-omico-bekerjasama-memajukan-pembangunan-ubat-onkologi-dipacu-biomarker\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.2\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Pakistan Daily  News Updates- Complete Zila News Updates all over Pakistan - Pakistan News, Daily Urdu News, Local News Pakistan, All District News Pakistan\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Fortrea dan Omico Bekerjasama Memajukan Pembangunan Ubat Onkologi Dipacu Biomarker\" \/>\n\t\t<meta property=\"og:description\" content=\"Sorotan Kerjasama ini bertujuan untuk mempercepatkan penyelidikan onkologi ketepatan di AustraliaMenggabungkan pengalaman Fortrea dalam kajian klinikal onkologi dengan program Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT) milik OmicoSecara bersama, Fortrea dan Omico meningkatkan kecekapan pemilihan tapak kajian serta mempercepatkan akses pesakit kepada kajian klinikal dipacu biomarker yang relevan melalui pemadanan pesakit dengan kajian tersebut\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/pakistaninewspaperlist.com\/news\/fortrea-dan-omico-bekerjasama-memajukan-pembangunan-ubat-onkologi-dipacu-biomarker\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/pakistaninewspaperlist.com\/news\/wp-content\/uploads\/2023\/08\/Pakistan-News.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/pakistaninewspaperlist.com\/news\/wp-content\/uploads\/2023\/08\/Pakistan-News.png\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-10-23T17:38:32+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-10-23T17:38:32+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Fortrea dan Omico Bekerjasama Memajukan Pembangunan Ubat Onkologi Dipacu Biomarker\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Sorotan Kerjasama ini bertujuan untuk mempercepatkan penyelidikan onkologi ketepatan di AustraliaMenggabungkan pengalaman Fortrea dalam kajian klinikal onkologi dengan program Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT) milik OmicoSecara bersama, Fortrea dan Omico meningkatkan kecekapan pemilihan tapak kajian serta mempercepatkan akses pesakit kepada kajian klinikal dipacu biomarker yang relevan melalui pemadanan pesakit dengan kajian tersebut\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/pakistaninewspaperlist.com\/news\/wp-content\/uploads\/2023\/08\/Pakistan-News.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/fortrea-dan-omico-bekerjasama-memajukan-pembangunan-ubat-onkologi-dipacu-biomarker\\\/#blogposting\",\"name\":\"Fortrea dan Omico Bekerjasama Memajukan Pembangunan Ubat Onkologi Dipacu Biomarker\",\"headline\":\"Fortrea dan Omico Bekerjasama Memajukan Pembangunan Ubat Onkologi Dipacu Biomarker\",\"author\":{\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/author\\\/giasulhassan\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/ml.globenewswire.com\\\/Resource\\\/Download\\\/9fbbe00b-8782-464e-83e6-5843c563884a\"},\"datePublished\":\"2026-10-23T17:38:32+00:00\",\"dateModified\":\"2026-10-23T17:38:32+00:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/fortrea-dan-omico-bekerjasama-memajukan-pembangunan-ubat-onkologi-dipacu-biomarker\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/fortrea-dan-omico-bekerjasama-memajukan-pembangunan-ubat-onkologi-dipacu-biomarker\\\/#webpage\"},\"articleSection\":\"GlobeNewswire\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/fortrea-dan-omico-bekerjasama-memajukan-pembangunan-ubat-onkologi-dipacu-biomarker\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/category\\\/globenewswire\\\/#listItem\",\"name\":\"GlobeNewswire\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/category\\\/globenewswire\\\/#listItem\",\"position\":2,\"name\":\"GlobeNewswire\",\"item\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/category\\\/globenewswire\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/fortrea-dan-omico-bekerjasama-memajukan-pembangunan-ubat-onkologi-dipacu-biomarker\\\/#listItem\",\"name\":\"Fortrea dan Omico Bekerjasama Memajukan Pembangunan Ubat Onkologi Dipacu Biomarker\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/fortrea-dan-omico-bekerjasama-memajukan-pembangunan-ubat-onkologi-dipacu-biomarker\\\/#listItem\",\"position\":3,\"name\":\"Fortrea dan Omico Bekerjasama Memajukan Pembangunan Ubat Onkologi Dipacu Biomarker\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/category\\\/globenewswire\\\/#listItem\",\"name\":\"GlobeNewswire\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/#organization\",\"name\":\"Pakistan Daily  News Updates- Complete Zila News Updates all over Pakistan\",\"description\":\"Pakistan News, Daily Urdu News, Local News Pakistan, All District News Pakistan\",\"url\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/Pakistan-News.png\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/fortrea-dan-omico-bekerjasama-memajukan-pembangunan-ubat-onkologi-dipacu-biomarker\\\/#organizationLogo\",\"width\":191,\"height\":78,\"caption\":\"Pakistan-News\"},\"image\":{\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/fortrea-dan-omico-bekerjasama-memajukan-pembangunan-ubat-onkologi-dipacu-biomarker\\\/#organizationLogo\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/author\\\/giasulhassan\\\/#author\",\"url\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/author\\\/giasulhassan\\\/\",\"name\":\"Gias Ul Hassan\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/fortrea-dan-omico-bekerjasama-memajukan-pembangunan-ubat-onkologi-dipacu-biomarker\\\/#webpage\",\"url\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/fortrea-dan-omico-bekerjasama-memajukan-pembangunan-ubat-onkologi-dipacu-biomarker\\\/\",\"name\":\"Fortrea dan Omico Bekerjasama Memajukan Pembangunan Ubat Onkologi Dipacu Biomarker\",\"description\":\"Sorotan Kerjasama ini bertujuan untuk mempercepatkan penyelidikan onkologi ketepatan di AustraliaMenggabungkan pengalaman Fortrea dalam kajian klinikal onkologi dengan program Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT) milik OmicoSecara bersama, Fortrea dan Omico meningkatkan kecekapan pemilihan tapak kajian serta mempercepatkan akses pesakit kepada kajian klinikal dipacu biomarker yang relevan melalui pemadanan pesakit dengan kajian tersebut\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/fortrea-dan-omico-bekerjasama-memajukan-pembangunan-ubat-onkologi-dipacu-biomarker\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/author\\\/giasulhassan\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/author\\\/giasulhassan\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/ml.globenewswire.com\\\/Resource\\\/Download\\\/9fbbe00b-8782-464e-83e6-5843c563884a\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/fortrea-dan-omico-bekerjasama-memajukan-pembangunan-ubat-onkologi-dipacu-biomarker\\\/#mainImage\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/fortrea-dan-omico-bekerjasama-memajukan-pembangunan-ubat-onkologi-dipacu-biomarker\\\/#mainImage\"},\"datePublished\":\"2026-10-23T17:38:32+00:00\",\"dateModified\":\"2026-10-23T17:38:32+00:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/#website\",\"url\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/\",\"name\":\"Pakistan Daily  News Updates- Complete Zila News Updates all over Pakistan\",\"description\":\"Pakistan News, Daily Urdu News, Local News Pakistan, All District News Pakistan\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/pakistaninewspaperlist.com\\\/news\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Fortrea dan Omico Bekerjasama Memajukan Pembangunan Ubat Onkologi Dipacu Biomarker","description":"Sorotan Kerjasama ini bertujuan untuk mempercepatkan penyelidikan onkologi ketepatan di AustraliaMenggabungkan pengalaman Fortrea dalam kajian klinikal onkologi dengan program Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT) milik OmicoSecara bersama, Fortrea dan Omico meningkatkan kecekapan pemilihan tapak kajian serta mempercepatkan akses pesakit kepada kajian klinikal dipacu biomarker yang relevan melalui pemadanan pesakit dengan kajian tersebut","canonical_url":"https:\/\/pakistaninewspaperlist.com\/news\/fortrea-dan-omico-bekerjasama-memajukan-pembangunan-ubat-onkologi-dipacu-biomarker\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/pakistaninewspaperlist.com\/news\/fortrea-dan-omico-bekerjasama-memajukan-pembangunan-ubat-onkologi-dipacu-biomarker\/#blogposting","name":"Fortrea dan Omico Bekerjasama Memajukan Pembangunan Ubat Onkologi Dipacu Biomarker","headline":"Fortrea dan Omico Bekerjasama Memajukan Pembangunan Ubat Onkologi Dipacu Biomarker","author":{"@id":"https:\/\/pakistaninewspaperlist.com\/news\/author\/giasulhassan\/#author"},"publisher":{"@id":"https:\/\/pakistaninewspaperlist.com\/news\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/ml.globenewswire.com\/Resource\/Download\/9fbbe00b-8782-464e-83e6-5843c563884a"},"datePublished":"2026-10-23T17:38:32+00:00","dateModified":"2026-10-23T17:38:32+00:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/pakistaninewspaperlist.com\/news\/fortrea-dan-omico-bekerjasama-memajukan-pembangunan-ubat-onkologi-dipacu-biomarker\/#webpage"},"isPartOf":{"@id":"https:\/\/pakistaninewspaperlist.com\/news\/fortrea-dan-omico-bekerjasama-memajukan-pembangunan-ubat-onkologi-dipacu-biomarker\/#webpage"},"articleSection":"GlobeNewswire"},{"@type":"BreadcrumbList","@id":"https:\/\/pakistaninewspaperlist.com\/news\/fortrea-dan-omico-bekerjasama-memajukan-pembangunan-ubat-onkologi-dipacu-biomarker\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/pakistaninewspaperlist.com\/news\/#listItem","position":1,"name":"Home","item":"https:\/\/pakistaninewspaperlist.com\/news\/","nextItem":{"@type":"ListItem","@id":"https:\/\/pakistaninewspaperlist.com\/news\/category\/globenewswire\/#listItem","name":"GlobeNewswire"}},{"@type":"ListItem","@id":"https:\/\/pakistaninewspaperlist.com\/news\/category\/globenewswire\/#listItem","position":2,"name":"GlobeNewswire","item":"https:\/\/pakistaninewspaperlist.com\/news\/category\/globenewswire\/","nextItem":{"@type":"ListItem","@id":"https:\/\/pakistaninewspaperlist.com\/news\/fortrea-dan-omico-bekerjasama-memajukan-pembangunan-ubat-onkologi-dipacu-biomarker\/#listItem","name":"Fortrea dan Omico Bekerjasama Memajukan Pembangunan Ubat Onkologi Dipacu Biomarker"},"previousItem":{"@type":"ListItem","@id":"https:\/\/pakistaninewspaperlist.com\/news\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/pakistaninewspaperlist.com\/news\/fortrea-dan-omico-bekerjasama-memajukan-pembangunan-ubat-onkologi-dipacu-biomarker\/#listItem","position":3,"name":"Fortrea dan Omico Bekerjasama Memajukan Pembangunan Ubat Onkologi Dipacu Biomarker","previousItem":{"@type":"ListItem","@id":"https:\/\/pakistaninewspaperlist.com\/news\/category\/globenewswire\/#listItem","name":"GlobeNewswire"}}]},{"@type":"Organization","@id":"https:\/\/pakistaninewspaperlist.com\/news\/#organization","name":"Pakistan Daily  News Updates- Complete Zila News Updates all over Pakistan","description":"Pakistan News, Daily Urdu News, Local News Pakistan, All District News Pakistan","url":"https:\/\/pakistaninewspaperlist.com\/news\/","logo":{"@type":"ImageObject","url":"https:\/\/pakistaninewspaperlist.com\/news\/wp-content\/uploads\/2023\/08\/Pakistan-News.png","@id":"https:\/\/pakistaninewspaperlist.com\/news\/fortrea-dan-omico-bekerjasama-memajukan-pembangunan-ubat-onkologi-dipacu-biomarker\/#organizationLogo","width":191,"height":78,"caption":"Pakistan-News"},"image":{"@id":"https:\/\/pakistaninewspaperlist.com\/news\/fortrea-dan-omico-bekerjasama-memajukan-pembangunan-ubat-onkologi-dipacu-biomarker\/#organizationLogo"}},{"@type":"Person","@id":"https:\/\/pakistaninewspaperlist.com\/news\/author\/giasulhassan\/#author","url":"https:\/\/pakistaninewspaperlist.com\/news\/author\/giasulhassan\/","name":"Gias Ul Hassan"},{"@type":"WebPage","@id":"https:\/\/pakistaninewspaperlist.com\/news\/fortrea-dan-omico-bekerjasama-memajukan-pembangunan-ubat-onkologi-dipacu-biomarker\/#webpage","url":"https:\/\/pakistaninewspaperlist.com\/news\/fortrea-dan-omico-bekerjasama-memajukan-pembangunan-ubat-onkologi-dipacu-biomarker\/","name":"Fortrea dan Omico Bekerjasama Memajukan Pembangunan Ubat Onkologi Dipacu Biomarker","description":"Sorotan Kerjasama ini bertujuan untuk mempercepatkan penyelidikan onkologi ketepatan di AustraliaMenggabungkan pengalaman Fortrea dalam kajian klinikal onkologi dengan program Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT) milik OmicoSecara bersama, Fortrea dan Omico meningkatkan kecekapan pemilihan tapak kajian serta mempercepatkan akses pesakit kepada kajian klinikal dipacu biomarker yang relevan melalui pemadanan pesakit dengan kajian tersebut","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/pakistaninewspaperlist.com\/news\/#website"},"breadcrumb":{"@id":"https:\/\/pakistaninewspaperlist.com\/news\/fortrea-dan-omico-bekerjasama-memajukan-pembangunan-ubat-onkologi-dipacu-biomarker\/#breadcrumblist"},"author":{"@id":"https:\/\/pakistaninewspaperlist.com\/news\/author\/giasulhassan\/#author"},"creator":{"@id":"https:\/\/pakistaninewspaperlist.com\/news\/author\/giasulhassan\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/ml.globenewswire.com\/Resource\/Download\/9fbbe00b-8782-464e-83e6-5843c563884a","@id":"https:\/\/pakistaninewspaperlist.com\/news\/fortrea-dan-omico-bekerjasama-memajukan-pembangunan-ubat-onkologi-dipacu-biomarker\/#mainImage"},"primaryImageOfPage":{"@id":"https:\/\/pakistaninewspaperlist.com\/news\/fortrea-dan-omico-bekerjasama-memajukan-pembangunan-ubat-onkologi-dipacu-biomarker\/#mainImage"},"datePublished":"2026-10-23T17:38:32+00:00","dateModified":"2026-10-23T17:38:32+00:00"},{"@type":"WebSite","@id":"https:\/\/pakistaninewspaperlist.com\/news\/#website","url":"https:\/\/pakistaninewspaperlist.com\/news\/","name":"Pakistan Daily  News Updates- Complete Zila News Updates all over Pakistan","description":"Pakistan News, Daily Urdu News, Local News Pakistan, All District News Pakistan","inLanguage":"en-US","publisher":{"@id":"https:\/\/pakistaninewspaperlist.com\/news\/#organization"}}]},"og:locale":"en_US","og:site_name":"Pakistan Daily  News Updates- Complete Zila News Updates all over Pakistan - Pakistan News, Daily Urdu News, Local News Pakistan, All District News Pakistan","og:type":"article","og:title":"Fortrea dan Omico Bekerjasama Memajukan Pembangunan Ubat Onkologi Dipacu Biomarker","og:description":"Sorotan Kerjasama ini bertujuan untuk mempercepatkan penyelidikan onkologi ketepatan di AustraliaMenggabungkan pengalaman Fortrea dalam kajian klinikal onkologi dengan program Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT) milik OmicoSecara bersama, Fortrea dan Omico meningkatkan kecekapan pemilihan tapak kajian serta mempercepatkan akses pesakit kepada kajian klinikal dipacu biomarker yang relevan melalui pemadanan pesakit dengan kajian tersebut","og:url":"https:\/\/pakistaninewspaperlist.com\/news\/fortrea-dan-omico-bekerjasama-memajukan-pembangunan-ubat-onkologi-dipacu-biomarker\/","og:image":"https:\/\/pakistaninewspaperlist.com\/news\/wp-content\/uploads\/2023\/08\/Pakistan-News.png","og:image:secure_url":"https:\/\/pakistaninewspaperlist.com\/news\/wp-content\/uploads\/2023\/08\/Pakistan-News.png","article:published_time":"2026-10-23T17:38:32+00:00","article:modified_time":"2026-10-23T17:38:32+00:00","twitter:card":"summary_large_image","twitter:title":"Fortrea dan Omico Bekerjasama Memajukan Pembangunan Ubat Onkologi Dipacu Biomarker","twitter:description":"Sorotan Kerjasama ini bertujuan untuk mempercepatkan penyelidikan onkologi ketepatan di AustraliaMenggabungkan pengalaman Fortrea dalam kajian klinikal onkologi dengan program Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT) milik OmicoSecara bersama, Fortrea dan Omico meningkatkan kecekapan pemilihan tapak kajian serta mempercepatkan akses pesakit kepada kajian klinikal dipacu biomarker yang relevan melalui pemadanan pesakit dengan kajian tersebut","twitter:image":"https:\/\/pakistaninewspaperlist.com\/news\/wp-content\/uploads\/2023\/08\/Pakistan-News.png"},"aioseo_meta_data":[],"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/pakistaninewspaperlist.com\/news\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/pakistaninewspaperlist.com\/news\/category\/globenewswire\/\" title=\"GlobeNewswire\">GlobeNewswire<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tFortrea dan Omico Bekerjasama Memajukan Pembangunan Ubat Onkologi Dipacu Biomarker\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/pakistaninewspaperlist.com\/news\/"},{"label":"GlobeNewswire","link":"https:\/\/pakistaninewspaperlist.com\/news\/category\/globenewswire\/"},{"label":"Fortrea dan Omico Bekerjasama Memajukan Pembangunan Ubat Onkologi Dipacu Biomarker","link":"https:\/\/pakistaninewspaperlist.com\/news\/fortrea-dan-omico-bekerjasama-memajukan-pembangunan-ubat-onkologi-dipacu-biomarker\/"}],"_links":{"self":[{"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/posts\/114875","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/comments?post=114875"}],"version-history":[{"count":0,"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/posts\/114875\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/media\/114876"}],"wp:attachment":[{"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/media?parent=114875"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/categories?post=114875"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/tags?post=114875"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}